CELGENE QUANTICEL RES INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	90
#2	EPO (European Patent Office)	35
#3	Israel	16
#4	Canada	15
#5	Mexico	15
#6	Chile	14
#7	Republic of Korea	14
#8	WIPO (World Intellectual Property Organization)	14
#9	Argentina	12
#10	Brazil	12
#11	China	12
#12	Ecuador	10
#13	Singapore	10
#14	Japan	6
#15	Taiwan	6
#16	Peru	5
#17	South Africa	5
#18	EAPO (Eurasian Patent Organization)	4
#19	Philippines	4
#20	Hungary	3
#21	Colombia	2
#22	Hong Kong	2
#23	Nicaragua	2
#24	Costa Rica	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Organic chemistry methods
#5	Enzymes
#6	Microorganisms
#7	Measuring microorganism processes

Publication	Filing date	Title
WO2020023438A2	2019-07-23	Process for the preparation of bromodomain inhibitor
US2018296543A1	2018-04-18	Therapeutic compounds
WO2018081475A1	2017-10-26	Bromodomain and extra-terminal protein inhibitor combination therapy
US2018042914A1	2017-10-19	Bromodomain inhibitor
WO2018075796A1	2017-10-19	Bromodomain inhibitor
US2017298044A1	2017-04-13	Histone demethylase inhibitors
EP3430008A1	2017-03-15	Histone demethylase inhibitors
EP3436445A1	2017-03-15	Histone demethylase inhibitors
CN108698997A	2016-12-27	Histone demethylase inhibitors
WO2017112703A1	2016-12-20	Bromodomain and extra-terminal protein inhibitor combination therapy
TW201642860A	2016-04-19	Bromodomain inhibitor
AR104259A1	2016-04-14	BROMODOMINUM INHIBITORS
US2016194306A1	2016-03-15	Histone demethylase inhibitors
US2016194323A1	2016-03-15	Histone demethylase inhibitors
KR20170048590A	2015-09-15	Histone demethylase inhibitors
KR20170045342A	2015-09-03	Inhibitors of lysine specific demethylase-1
EP3164509A1	2015-06-30	Inhibitors of lysine specific demethylase-1
MX2017000179A	2015-06-26	Inhibitors of lysine specific demethylase-1.
EA031200B1	2015-06-25	Histone methylase inhibitors
TW201623254A	2015-04-30	Inhibitors of lysine specific demethylase-1